Visualitza per autor "ciardiello, davide"
Ara mostrant els elements 1-7 d 7
-
Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
Ciardiello, Davide; Martin, Giulia; Famiglietti, Vincenzo; Napolitano, Stefania; Troiani, Teresa; Ros Montañá, Fco. Javier; Elez Fernandez, Mª Elena; De Falco, Vincenzo (MDPI, 2021-04-17) -
BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Sardo, Emilia; Mulet Margalef, Núria; Salva Ballabrera, Francesc; Argilés Martinez, Guillem; Martini, Giulia; Ciardiello, Davide; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2021-01) -
Clinical development of therapies targeting TGFβ: current knowledge and future perspectives
Ciardiello, Davide; Elez Fernandez, Mª Elena; Tabernero Caturla, Josep; Seoane Suarez, Joan (Elsevier, 2020-10) -
Clinical management of metastatic colorectal cancer in the era of precision medicine
Ciardiello, Davide; Martini, Giulia; Napolitano, Stefania; Tabernero Caturla, Josep; Cervantes, Andrés; Ciardiello, Fortunato (Wiley, 2022-07) -
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer
MARTINI, Giulia; belli, valentina; Napolitano, Stefania; Ciaramella, Vincenza; ciardiello, davide; Belli, Andrea; Puig Borreil, Isabel; Ramírez Corpas, Lorena; Chicote Ramos, Irene; Mancuso, Francesco Mattia; Caratù, Ginevra; Serres-Créixams, Xavier; fasani, roberta; Jiménez Flores, José Antonio; Ros, Javier; Baraibar, Iosune; Vivancos, Ana; Elez, Elena ; Palmer, Hector; Argilés Martinez, Guillem; Tabernero, Josep; Dienstmann, Rodrigo (Elsevier, 2023-06) -
Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
Martini, Giulia; Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Cuadra-Urteaga, Jose Luis; Salva Ballabrera, Francesc; Ciardiello, Davide; Mulet Margalef, Núria; Argilés Martinez, Guillem; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Dienstmann, Rodrigo (SAGE Publications, 2020-07-24) -
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
Vitiello, Pietro Paolo; Martini, Giulia; Ciardiello, Davide; Belli, Valentina; Matrone, Nunzia; Cardone, Claudia (BMC, 2019-01-28)